Rivaroxaban Tablets
Deep Vein Thrombosis, Pulmonary Embolism
10mg
Rivaroxaban 10mg tablets, used in the management of deep vein thrombosis, pulmonary embolism and stroke prevention in atrial fibrillation.
From$0.85/ tabletView
Rivaroxaban
Rivaroxaban (marketed as Xarelto) is a direct oral anticoagulant used to manage blood clotting. It is often used for Stroke Prevention in Atrial Fibrillation and to address conditions like Deep Vein Thrombosis. Generic formulations of this medication are available.
Key points
- Interrupts clot formation by blocking Factor Xa, the enzyme that turns prothrombin into thrombin during the clotting cascade.
- Treats three related conditions: stroke prevention in atrial fibrillation, pulmonary embolism, and deep vein thrombosis.
- Comes as both a standard tablet and a film-coated tablet, available as the original Xarelto brand or as generics.
- Combining it with NSAIDs or antiplatelet drugs may raise the risk of serious bleeding and needs careful medical oversight.
What is Rivaroxaban?
Rivaroxaban is a pharmaceutical blood thinner known as a Factor Xa inhibitor. It prevents the formation of blood clots within the circulatory system by blocking a specific enzyme responsible for clotting. Patients often seek out this medication to maintain cardiovascular health as part of a management plan aligned with Heart & Blood Pressure support recommendations.
What Rivaroxaban is used for
This medication is primarily used to lower the risk of unwanted clots, particularly in those with specific heart rhythm conditions or following surgery. It is a standard option for long-term Stroke Prevention in Atrial Fibrillation, as it ensures blood flows without creating obstructing masses. It also assists in the ongoing management of Pulmonary Embolism and Deep Vein Thrombosis.
How does Rivaroxaban work?
Rivaroxaban works by selectively inhibiting Factor Xa, an enzyme within the body that converts prothrombin into thrombin. Thrombin is necessary for forming the mesh of fibres that makes blood clot. By blocking this step, the medication interferes with the body clotting cascade, making it much harder for clots to form or grow in vulnerable vessels.
Rivaroxaban brands and forms
The originator brand Xarelto established this medication as a standard for anticoagulation therapy. Generic tablet options offer an alternative for patients. It is available as a standard tablet or film-coated tablet, which is designed to ensure consistent absorption. Finding the right formulation depends on the dosage directed by a medical professional.
Safety overview for Rivaroxaban
What to check before using this medicine
Individuals with liver or kidney impairment, or those at high risk of bleeding, need careful oversight. Always disclose other medications, particularly antiplatelet drugs or non-steroidal anti-inflammatory drugs, as these may increase the risk of haemorrhage.
Possible reactions and tolerability
Common concerns include an increased risk of bruising or bleeding, such as nosebleeds or bleeding gums. Some users may experience fatigue or gastrointestinal discomfort. Report any signs of unexplained bleeding, severe headache or dizziness to a doctor immediately.
Interactions and health factors
Rivaroxaban interacts with various compounds, including certain antifungal, antiviral, and seizure medications. Avoid self-adjusting your dose or stopping the medication abruptly, as this can increase the risk of clotting events. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.